<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Uncoupling of cardiac gap junction channels is an important arrhythmogenic mechanism in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion </plain></SENT>
<SENT sid="1" pm="."><plain>Antiarrhythmic <z:chebi fb="7" ids="16670">peptide</z:chebi> AAP10 (H-Gly-Ala-Gly-<z:chebi fb="1" ids="17368">Hyp</z:chebi>-Pro-Tyr-CONH(2)) has been shown to prevent <z:hpo ids='HP_0001941'>acidosis</z:hpo>-induced uncoupling and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-related increase in dispersion </plain></SENT>
<SENT sid="2" pm="."><plain>Previous structure-effect investigations and subsequent computer modeling studies indicated that the <z:chebi fb="1" ids="36809">tricyclic antidepressant</z:chebi> <z:chebi fb="0" ids="47781">desipramine</z:chebi> may exert similar effects as AAP10 </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We assessed the binding of (14)C-AAP10 to membranes of rabbit cardiac ventricles and its displacement with <z:chebi fb="0" ids="47781">desipramine</z:chebi> in a classical radioligand binding and competition study </plain></SENT>
<SENT sid="4" pm="."><plain>Gap junction currents were measured between isolated pairs of human atrial cardiomyocytes under <z:mpath ids='MPATH_458'>normal</z:mpath> and acidotic (pH 6.3) conditions with or without 1 μmol/l <z:chebi fb="0" ids="47781">desipramine</z:chebi> using dual whole-cell voltage clamp </plain></SENT>
<SENT sid="5" pm="."><plain>The effect of 1 μmol/l <z:chebi fb="0" ids="47781">desipramine</z:chebi> was assessed in isolated rabbit hearts (Langendorff technique) undergoing local <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> by <z:e sem="disease" ids="C0151814" disease_type="Disease or Syndrome" abbrv="">coronary occlusion</z:e> with 256-channel electrophysiological mapping and subsequent analysis of connexin43 (Cx43) expression, phosphorylation (Western blot), and subcellular localization (immunohistology) </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: We found saturable (14)C-AAP10 binding to cardiac membranes (K (D), 0.29 ± 0.11 nmol/l; B (max), 42.5 ± 7.2 pmol/mg) which could be displaced by <z:chebi fb="0" ids="47781">desipramine</z:chebi> with a K (D.High) = 0.14 μmol/l and a K (D.Low) = 22 μmol/l </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0001941'>Acidosis</z:hpo> reduced the gap junction conductance in human cardiomyocyte pairs from 24.1 ± 4.7 to 11.5 ± 2.5 nS, which could be significantly reversed by <z:chebi fb="0" ids="47781">desipramine</z:chebi> (26.6 ± 4.8 nS) </plain></SENT>
<SENT sid="8" pm="."><plain>In isolated hearts, <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> resulted in significantly increased dispersion of activation-recovery intervals, loss of membrane Cx43, and dephosphorylation of Cx43, which <z:hpo ids='HP_0000001'>all</z:hpo> could be prevented by <z:chebi fb="0" ids="47781">desipramine</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: <z:chebi fb="0" ids="47781">Desipramine</z:chebi> seems to prevent the uncoupling of cardiac gap junctions and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-related increase in dispersion </plain></SENT>
</text></document>